Fate Therapeutics Inc (NAS:FATE)
$ 2.565 +0.050 (+1.98%) Market Cap: 307.34 Mil Enterprise Value: 229.25 Mil PE Ratio: 0 PB Ratio: 1.95 GF Score: 33/100

Fate Therapeutics Inc (FATE) Transcripts

  • 1